A systematic comparison of clinically viable nanomedicines targeting HMG-CoA reductase in inflammatory atherosclerosis
Amr Alaarg, Max L. Senders, Aida Varela-Moreira, Carlos Pérez-Medina, Yiming Zhao, Jun Tang, Francois Fay, Thomas Reiner, Zahi A. Fayad, Wim E. Hennink, Josbert M. Metselaar, Willem J.M. Mulder, Gert Storm
Research output: Contribution to journal › Article › peer-review
44Scopus
citations
Fingerprint
Dive into the research topics of 'A systematic comparison of clinically viable nanomedicines targeting HMG-CoA reductase in inflammatory atherosclerosis'. Together they form a unique fingerprint.